Swertisin

CAS No. 6991-10-2

Swertisin ( —— )

Catalog No. M24716 CAS No. 6991-10-2

Swertisin, a novel herbal biomolecule, shows a strong antihyperglycemic action.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 237 In Stock
10MG 354 In Stock
25MG 581 In Stock
50MG 799 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Swertisin
  • Note
    Research use only, not for human use.
  • Brief Description
    Swertisin, a novel herbal biomolecule, shows a strong antihyperglycemic action.
  • Description
    Swertisin, a novel herbal biomolecule, shows a strong antihyperglycemic action. Swertisin is an adenosine A1 receptor antagonist, is known to have antidiabetic, anti-inflammatory and antioxidant effects.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    Adenosine A1?receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6991-10-2
  • Formula Weight
    446.4
  • Molecular Formula
    C22H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(OC)=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.A Small Molecule Swertisin from Enicostemma littorale Differentiates NIH3T3 Cells into Islet-Like Clusters and Restores Normoglycemia upon Transplantation in Diabetic Balb/c Mice.Evid Based Complement Alternat Med. 2013;2013:280392.
molnova catalog
related products
  • Physostigmine Salicy...

    Physostigmine is a parasympathomimetic alkaloid, specifically, a reversible cholinesterase inhibitor.

  • Adenosine 5'-monopho...

    Adenosine monophosphate (AMP), also known as 5'-adenylic acid, is a nucleotide that is used as a monomer in RNA.

  • GSK137647A

    GSK137647A is a selective FFA4 agonist.